Table 1.
| ||||
---|---|---|---|---|
Analog | R1 | R2 | LDHA (w/o EDTA) IC50 ± SD (μM) |
LDHA (w/EDTA) IC50 ± SD (μM) |
1 | NA | NA | 1.02 ± 0.07 | 1.34 ± 0.15 |
5 | CF3 | Ph | 22.2 ± 2.4 b | 28.8 ± 1.9 |
6 | Me | Ph | 15.4 ± 12b | >57 |
7 | NH2 | Ph | 26.7 ± 3 b | >57 |
8 | iPr | Ph | >57 | >57 |
9 | CHF2 | Ph | >57 | >57 |
10 | NHAc | Ph | 9.57 ± 1.8 b | >57 |
11 | OH | Ph | 0.144 ± 0.009 | >57 |
12 | CF3 | 2-Cl-Ph | >57 | >57 |
13 | CF3 | 3-Cl-Ph | >57 | >57 |
14 | CF3 | 4-Cl-Ph | 26.6 ± 0.1 | 27.7 ± 1.9 |
15 | CF3 | 4-F-Ph | 23.4 ± 5.7 | 32.3 ± 2.1 |
16 | OH | 4-F-Ph | 0.095 ± 0.001 | >57 |
17 | OH | 3-Cl-Ph | 0.168 ± 0.001 | >57 |
18 | OH | 2-F-Ph | 0.134 ± 0.001 | >57 |
19 | OH | 3-F-Ph | 0.162 ± 0.011 | >57 |
20 | OH | 3-CF3-Ph | 0.189 ± 0.001 | >57 |
21 | OH | 3-OCF3-Ph | 0.299 ± 0.001 | >57 |
22 | OH | 4-OMe-Ph | 0.229 ± 0.015 | >57 |
23 | OH | 2-pyridine | 1.02 ± 0.07 | >57 |
24 | OH | 4-pyridine | 0.669 ± 0.001 | >57 |
25 | OH | cyclohexyl | 1.10 ± 0.08 | >57 |
26 | OH | 1-naphthyl | 0.213 ± 0.024 | >57 |
27 | OH | 3,4-F-Ph | 0.150 ± 0.001 | >57 |
28 | OH | 3,4-Cl-Ph | 0.106 ± 0.001 | >57 |
29 | OH | 2,4-F-Ph | 0.084 ± 0.001 | >57 |
30 | OH | 3,5-F-Ph | 0.110 ± 0.007 | >57 |
31 | OH | (3-Ph)-Ph | 0.266 ± 0.001 | >57 |
32 | OH | 3-(2-F-Ph)-Ph | 0.095 ± 0.001 | >57 |
IC50 values represent the half maximal (50%) inhibitory concentration as determined in the HTS assay (n = 3) using a 22-dose response in 1536-well format.
Max. Response was less than 50% and thus IC50 values should be considered as lower confidence.